PeptideDB

Laciniatoside V

CAS No.: 120416-05-9

Laciniatoside V is a metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Laciniatoside V is a metabolite.
molecular weight 586.587
Molecular formula C27H38O14
CAS 120416-05-9
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Soe CZ, Pakchung AA, Codd R. Dinuclear [(V(V)O(putrebactin))2(μ-OCH3)2] formed in solution as established from LC-MS measurements using 50V-enriched V2O5. Inorg Chem. 2014 Jun 2;53(11):5852-61. doi: 10.1021/ic500787v. Epub 2014 May 16. PubMed PMID: 24834956. 2. Chen T, Li TQ, Yang JY. Damage suffered by swamp morning glory (Ipomoea aquatica Forsk) exposed to vanadium (V). Environ Toxicol Chem. 2016 Mar;35(3):695-701. doi: 10.1002/etc.3226. Epub 2016 Feb 3. PubMed PMID: 26329124. 3. Ciprandi G, Comite P, Mussap M, De Amici M, Quaglini S, Barocci F, Marseglia GL, Scala E. Profiles of Birch Sensitization (Bet v 1, Bet v 2, and Bet v 4) and Oral Allergy Syndrome Across Italy. J Investig Allergol Clin Immunol. 2016;26(4):244-8. doi: 10.18176/jiaci.0041. PubMed PMID: 27470643. 4. Chakrabarti S, Wu X, Yang Z, Wu L, Yong SL, Zhang C, Hu K, Wang QK, Chen Q. MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):392-401. doi: 10.1161/CIRCEP.111.000206. Epub 2013 Feb 18. PubMed PMID: 23420830; PubMed Central PMCID: PMC3633223.